Boston Scientific (BSX) Gross Margin (2009 - 2026)
Boston Scientific recorded quarterly Gross Margin of 69.46% in Q1 2026, little changed quarter-over-quarter from 69.6% in Q4 2025, and up 62.0% year-over-year from 42.88% in Q1 2025.
Boston Scientific's Gross Margin history runs 18 years deep, the most recent figure standing at 69.46% for Q1 2026.
- In Q1 2026, Gross Margin rose 62.0% year-over-year to 69.46%; the TTM figure through Mar 2026 stood at 69.17% (up 51.0% YoY), while the FY2025 annual figure was 69.01%, up 41.0% from the prior year.
- Gross Margin came in at 69.46% for Q1 2026 at Boston Scientific, roughly flat from 69.6% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 70.63% in Q2 2023 to a low of 67.65% in Q2 2025.
- A 5-year average of 69.01% and a median of 68.85% in 2022 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin surged 180 bps in 2023 and tumbled 152 bps in 2025, its largest moves.
- Boston Scientific's Gross Margin stood at 68.85% in 2022, then rose by 1 bps to 69.23% in 2023, then dropped by 2 bps to 67.86% in 2024, then climbed by 3 bps to 69.6% in 2025, then slipped by 0 bps to 69.46% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 69.46%, 69.6%, and 69.93% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 72.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.46% |
| Dec 31, 2025 | 69.60% |
| Sep 30, 2025 | 69.93% |
| Jun 30, 2025 | 67.65% |
| Mar 31, 2025 | 68.84% |
| Dec 31, 2024 | 67.86% |
| Sep 30, 2024 | 68.83% |
| Jun 30, 2024 | 69.17% |
| Mar 31, 2024 | 68.67% |
| Dec 31, 2023 | 69.23% |
| Sep 30, 2023 | 68.78% |
| Jun 30, 2023 | 70.63% |
| Mar 31, 2023 | 69.31% |
| Dec 31, 2022 | 68.85% |
| Sep 30, 2022 | 69.12% |
| Jun 30, 2022 | 68.83% |
| Mar 31, 2022 | 68.44% |
| Dec 31, 2021 | 68.92% |
| Sep 30, 2021 | 69.30% |
| Jun 30, 2021 | 69.29% |
| Mar 31, 2021 | 67.51% |
| Dec 31, 2020 | 63.05% |
| Sep 30, 2020 | 67.32% |
| Jun 30, 2020 | 60.51% |
| Mar 31, 2020 | 68.31% |
| Dec 31, 2019 | 70.73% |
| Sep 30, 2019 | 71.30% |
| Jun 30, 2019 | 71.19% |
| Mar 31, 2019 | 70.72% |
| Dec 31, 2018 | 71.53% |
| Sep 30, 2018 | 71.88% |
| Jun 30, 2018 | 70.32% |
| Mar 31, 2018 | 71.75% |
| Dec 31, 2017 | 72.01% |
| Sep 30, 2017 | 71.33% |
| Jun 30, 2017 | 72.00% |
| Mar 31, 2017 | 69.91% |
| Dec 31, 2016 | 71.75% |
| Sep 30, 2016 | 71.78% |
| Jun 30, 2016 | 69.94% |
| Mar 31, 2016 | 70.82% |
| Dec 31, 2015 | 71.03% |
| Sep 30, 2015 | 71.45% |
| Jun 30, 2015 | 70.70% |
| Mar 31, 2015 | 70.59% |
| Dec 31, 2014 | 70.38% |
| Sep 30, 2014 | 70.21% |
| Jun 30, 2014 | 69.94% |
| Mar 31, 2014 | 69.73% |
| Dec 31, 2013 | 69.75% |
| Sep 30, 2013 | 70.61% |
| Jun 30, 2013 | 70.70% |
| Mar 31, 2013 | 67.18% |
| Dec 31, 2012 | 68.04% |
| Sep 30, 2012 | 67.84% |
| Jun 30, 2012 | 68.38% |
| Mar 31, 2012 | 66.18% |
| Dec 31, 2011 | 64.29% |
| Sep 30, 2011 | 63.71% |
| Jun 30, 2011 | 65.16% |
| Mar 31, 2011 | 67.22% |
| Dec 31, 2010 | 67.03% |
| Sep 30, 2010 | 67.48% |
| Jun 30, 2010 | 66.08% |
| Mar 31, 2010 | 66.17% |
| Dec 31, 2009 | 65.85% |
| Sep 30, 2009 | 68.94% |
| Jun 30, 2009 | 69.62% |
| Mar 31, 2009 | 69.80% |